AAAAAA

   
Results: 1-25 |
Results: 25
ONE-HOUR PACLITAXEL PLUS CARBOPLATIN IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - RESULTS OF A MULTICENTER, PHASE-II TRIAL
Authors: HAINSWORTH JD URBA WJ HON JK THOMPSON KA STAGG MP HOPKINS LG THOMAS M GRECO FA
Citation: Jd. Hainsworth et al., ONE-HOUR PACLITAXEL PLUS CARBOPLATIN IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - RESULTS OF A MULTICENTER, PHASE-II TRIAL, European journal of cancer, 34(5), 1998, pp. 654-658
LIPOFECTION INDIRECTLY INCREASES EXPRESSION OF ENDOGENOUS MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES ON TUMOR-CELLS
Authors: FOX BA DRURY M HU HM CAO ZW HUNTZICKER EG QIE WX URBA WJ
Citation: Ba. Fox et al., LIPOFECTION INDIRECTLY INCREASES EXPRESSION OF ENDOGENOUS MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES ON TUMOR-CELLS, Cancer gene therapy, 5(5), 1998, pp. 307-312
PERFORIN DEFICIENT T-CELLS FROM TUMOR VACCINE-DRAINING LYMPH-NODES MEDIATE TUMOR-REGRESSION
Authors: WINTER K HU HM URBA WJ FOX BA
Citation: K. Winter et al., PERFORIN DEFICIENT T-CELLS FROM TUMOR VACCINE-DRAINING LYMPH-NODES MEDIATE TUMOR-REGRESSION, The FASEB journal, 12(4), 1998, pp. 1617-1617
TUMOR-BEARING MICE HAVE DIMINISHED CAPACITY TO GENERATE THERAPEUTIC TYPE-1 T-CELLS IN TUMOR VACCINE DRAINING LYMPH-NODES
Authors: HU HM URBA WJ FOX BA
Citation: Hm. Hu et al., TUMOR-BEARING MICE HAVE DIMINISHED CAPACITY TO GENERATE THERAPEUTIC TYPE-1 T-CELLS IN TUMOR VACCINE DRAINING LYMPH-NODES, The FASEB journal, 12(4), 1998, pp. 1618-1618
A PHASE-II STUDY OF CARBOPLATIN, CISPLATIN, INTERFERON-ALPHA, AND TAMOXIFEN FOR PATIENTS WITH METASTATIC MELANOMA
Authors: GAUSE BL SHARFMAN WH JANIK JE CURTI BD STEIS RG URBA WJ SMITH JW ALVORD WG LONGO SL
Citation: Bl. Gause et al., A PHASE-II STUDY OF CARBOPLATIN, CISPLATIN, INTERFERON-ALPHA, AND TAMOXIFEN FOR PATIENTS WITH METASTATIC MELANOMA, Cancer investigation, 16(6), 1998, pp. 374-380
GENE-MODIFIED TUMOR VACCINE WITH THERAPEUTIC POTENTIAL SHIFTS TUMOR-SPECIFIC T-CELL RESPONSE FROM A TYPE-2 TO A TYPE-1 CYTOKINE PROFILE
Authors: HU HM URBA WJ FOX BA
Citation: Hm. Hu et al., GENE-MODIFIED TUMOR VACCINE WITH THERAPEUTIC POTENTIAL SHIFTS TUMOR-SPECIFIC T-CELL RESPONSE FROM A TYPE-2 TO A TYPE-1 CYTOKINE PROFILE, The Journal of immunology (1950), 161(6), 1998, pp. 3033-3041
PERIPHERAL T-LYMPHOCYTES FROM WOMEN WITH BREAST-CANCER EXHIBIT ABNORMAL PROTEIN EXPRESSION OF SEVERAL SIGNALING MOLECULES
Authors: KURT RA URBA WJ SMITH JW SCHOOF DD
Citation: Ra. Kurt et al., PERIPHERAL T-LYMPHOCYTES FROM WOMEN WITH BREAST-CANCER EXHIBIT ABNORMAL PROTEIN EXPRESSION OF SEVERAL SIGNALING MOLECULES, International journal of cancer, 78(1), 1998, pp. 16-20
GENETIC IMMUNIZATION OF PATIENTS WITH METASTATIC BREAST-CANCER USING A CD80 (B7.1)-MODIFIED, HLA-A2+, HER2 NEU+, ALLOGENEIC BREAST-CANCER CELL VACCINE PLUS GM-CSF/
Authors: SMITH JW SCHOOF DD DISIS ML BRANTZAWADSKI P WOOD W DORAN T JOHNSON E URBA WJ
Citation: Jw. Smith et al., GENETIC IMMUNIZATION OF PATIENTS WITH METASTATIC BREAST-CANCER USING A CD80 (B7.1)-MODIFIED, HLA-A2+, HER2 NEU+, ALLOGENEIC BREAST-CANCER CELL VACCINE PLUS GM-CSF/, Cancer gene therapy, 4(6), 1997, pp. 122-122
IMMUNIZATION OF METASTATIC BREAST-CANCER PATIENTS WITH CD80-MODIFIED BREAST-CANCER CELLS AND GM-CSF
Authors: SCHOOF DD SMITH JW BRANTZAWADSKI P WOOD W DORAN T JOHNSON E URBA WJ
Citation: Dd. Schoof et al., IMMUNIZATION OF METASTATIC BREAST-CANCER PATIENTS WITH CD80-MODIFIED BREAST-CANCER CELLS AND GM-CSF, Cancer gene therapy, 4(5), 1997, pp. 331-331
PHASE-II TRIAL OF INTERLEUKIN-1-ALPHA AND INDOMETHACIN IN TREATMENT OF METASTATIC MELANOMA
Authors: JANIK JE MILLER LL LONGO DL POWERS GC URBA WJ KOPP WC GAUSE BL CURTI BD FENTON RG OPPENHEIM JJ CONLON KC HOLMLUND JT SZNOL M SHARFMAN WH STEIS RG CREEKMORE SP ALVORD WG BEAUCHAMP AE SMITH JW
Citation: Je. Janik et al., PHASE-II TRIAL OF INTERLEUKIN-1-ALPHA AND INDOMETHACIN IN TREATMENT OF METASTATIC MELANOMA, Journal of the National Cancer Institute, 88(1), 1996, pp. 44-49
INDUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AFTER INTERLEUKIN-1 THERAPY IN PATIENTS WITH CANCER
Authors: KOPP WC URBA WJ RAGER HC ALVORD WG OPPENHEIM JJ SMITH JW LONGO DL
Citation: Wc. Kopp et al., INDUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AFTER INTERLEUKIN-1 THERAPY IN PATIENTS WITH CANCER, Clinical cancer research, 2(3), 1996, pp. 501-506
A PHASE-I RANDOMIZED STUDY OF SUBCUTANEOUS ADJUVANT IL-2 IN COMBINATION WITH AN AUTOLOGOUS TUMOR VACCINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
Authors: FENTON RG STEIS RG MADARA K ZEA AH OCHOA AC JANIK JE SMITH JW GAUSE BL SHARFMAN WH URBA WJ HANNA MG DEJAGER RL COYNE MX CROUCH RD GRAY P BEVERIDGE J CREEKMORE SP HOLMLUND J CURTI BD SZNOL M LONGO DL
Citation: Rg. Fenton et al., A PHASE-I RANDOMIZED STUDY OF SUBCUTANEOUS ADJUVANT IL-2 IN COMBINATION WITH AN AUTOLOGOUS TUMOR VACCINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 364-374
INFLUENCE OF INTERLEUKIN-2 REGIMENS ON CIRCULATING POPULATIONS OF LYMPHOCYTES AFTER ADOPTIVE TRANSFER OF ANTI-CD3-STIMULATED T-CELLS - RESULTS FROM A PHASE-I TRIAL IN CANCER-PATIENTS
Authors: CURTI BD OCHOA AC URBA WJ ALVORD WG KOPP WC POWERS G HAWK C CREEKMORE SP GAUSE BL JANIK JE HOLMLUND JT KREMERS P FENTON RG MILLER L SZNOL S SMITH JW SHARFMAN WH LONGO DL
Citation: Bd. Curti et al., INFLUENCE OF INTERLEUKIN-2 REGIMENS ON CIRCULATING POPULATIONS OF LYMPHOCYTES AFTER ADOPTIVE TRANSFER OF ANTI-CD3-STIMULATED T-CELLS - RESULTS FROM A PHASE-I TRIAL IN CANCER-PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 296-308
ENDOCRINE EFFECTS OF IL-1-ALPHA AND IL-1-BETA ADMINISTERED IN A PHASE-I TRIAL TO PATIENTS WITH ADVANCED CANCER
Authors: CURTI BD URBA WJ LONGO DL JANIK JE SHARFMAN WH MILLER LL CIZZA G SHIMIZU M OPPENHEIM JJ ALVORD WG SMITH JW
Citation: Bd. Curti et al., ENDOCRINE EFFECTS OF IL-1-ALPHA AND IL-1-BETA ADMINISTERED IN A PHASE-I TRIAL TO PATIENTS WITH ADVANCED CANCER, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 142-148
PHASE-I STUDY OF SUBCUTANEOUSLY ADMINISTERED INTERLEUKIN-2 IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED CANCER
Authors: GAUSE BL SZNOL M KOPP WC JANIK JE SMITH JW STEIS RG URBA WJ SHARFMAN W FENTON RG CREEKMORE SP HOLMLUND J CONLON KC VANDERMOLEN LA LONGO DL
Citation: Bl. Gause et al., PHASE-I STUDY OF SUBCUTANEOUSLY ADMINISTERED INTERLEUKIN-2 IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2234-2241
A PHASE-I CLINICAL-TRIAL OF FLAVONE-8-ACETIC ACID IN COMBINATION WITHINTERLEUKIN-2
Authors: HOLMLUND JT KOPP WC WILTROUT RH LONGO DL URBA WJ JANIK JE SZNOL M CONLON KC FENTON RG HORNUNG R MADARA K SHIELDS MA SMITH JW SHARFMAN W STEIS RG EWEL C MALSPEIS L CREEKMORE SP
Citation: Jt. Holmlund et al., A PHASE-I CLINICAL-TRIAL OF FLAVONE-8-ACETIC ACID IN COMBINATION WITHINTERLEUKIN-2, Journal of the National Cancer Institute, 87(2), 1995, pp. 134-136
ALTERATIONS IN T-CELL RECEPTOR AND SIGNAL-TRANSDUCTION MOLECULES IN MELANOMA PATIENTS
Authors: ZEA AH CURTI BD LONGO DL ALVORD WG STROBL SL MIZOGUCHI H CREEKMORE SP OSHEA JJ POWERS GC URBA WJ OCHOA AC
Citation: Ah. Zea et al., ALTERATIONS IN T-CELL RECEPTOR AND SIGNAL-TRANSDUCTION MOLECULES IN MELANOMA PATIENTS, Clinical cancer research, 1(11), 1995, pp. 1327-1335
PHASE I II TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, ZIDOVUDINE AND DIPYRIDAMOLE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, RENAL-CELL CARCINOMA AND MALIGNANT-MELANOMA/
Authors: SHARFMAN WH URBA WJ SMITH JW JANIK JE CURTI BD GAUSE BL HOLMLUND JT STEIS RG BEAUCHAMP AE LONGO DL
Citation: Wh. Sharfman et al., PHASE I II TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, ZIDOVUDINE AND DIPYRIDAMOLE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, RENAL-CELL CARCINOMA AND MALIGNANT-MELANOMA/, International journal of oncology, 6(3), 1995, pp. 579-583
POLARIZED HELPER T-CELL RESPONSES TO RENAL-CELL CARCINOMA (RCC)
Authors: SCHOOF DD URBA WJ WEINBERG AD
Citation: Dd. Schoof et al., POLARIZED HELPER T-CELL RESPONSES TO RENAL-CELL CARCINOMA (RCC), The FASEB journal, 9(4), 1995, pp. 1023-1023
LIPID COMPLEX-MEDIATED GENE-TRANSFER INTO FRESHLY ISOLATED TUMOR-CELLS FOR VACCINATION IMMUNOTHERAPY
Authors: ISA S HU HM VETTO JT URBA WJ FOX BA
Citation: S. Isa et al., LIPID COMPLEX-MEDIATED GENE-TRANSFER INTO FRESHLY ISOLATED TUMOR-CELLS FOR VACCINATION IMMUNOTHERAPY, Journal of cellular biochemistry, 1995, pp. 394-394
ANTI-IGM INDUCES TRANSFORMING GROWTH-FACTOR-BETA SENSITIVITY IN A HUMAN B-LYMPHOMA CELL-LINE - INHIBITION OF GROWTH IS ASSOCIATED WITH A DOWN-REGULATION OF MUTANT P53
Authors: BECKWITH M RUSCETTI FW SING GK URBA WJ LONGO DL
Citation: M. Beckwith et al., ANTI-IGM INDUCES TRANSFORMING GROWTH-FACTOR-BETA SENSITIVITY IN A HUMAN B-LYMPHOMA CELL-LINE - INHIBITION OF GROWTH IS ASSOCIATED WITH A DOWN-REGULATION OF MUTANT P53, Blood, 85(9), 1995, pp. 2461-2470
HODGKINS-DISEASE IN ADULTS .2.
Authors: URBA WJ LONGO DL
Citation: Wj. Urba et Dl. Longo, HODGKINS-DISEASE IN ADULTS .2., Investigative radiology, 28(9), 1993, pp. 848-859
HODGKINS-DISEASE IN ADULTS .1.
Authors: URBA WJ LONGO DL
Citation: Wj. Urba et Dl. Longo, HODGKINS-DISEASE IN ADULTS .1., Investigative radiology, 28(8), 1993, pp. 737-752
INTERSTITIAL PRESSURE OF SUBCUTANEOUS NODULES IN MELANOMA AND LYMPHOMA PATIENTS - CHANGES DURING TREATMENT
Authors: CURTI BD URBA WJ ALVORD WG JANIK JE SMITH JW MADARA K LONGO DL
Citation: Bd. Curti et al., INTERSTITIAL PRESSURE OF SUBCUTANEOUS NODULES IN MELANOMA AND LYMPHOMA PATIENTS - CHANGES DURING TREATMENT, Cancer research, 53(10), 1993, pp. 2204-2207
ERYTHROPOIETIN PRODUCTION - A POTENTIAL MARKER FOR INTERLEUKIN-2 INTERFERON-RESPONSIVE TUMORS
Authors: JANIK JE SZNOL M URBA WJ FIGLIN R BUKOWSKI RM FYFE G PIERCE WC BELLDEGRUN A SHARFMAN WH SMITH JW LONGO DL
Citation: Je. Janik et al., ERYTHROPOIETIN PRODUCTION - A POTENTIAL MARKER FOR INTERLEUKIN-2 INTERFERON-RESPONSIVE TUMORS, Cancer, 72(9), 1993, pp. 2656-2659
Risultati: 1-25 |